Our ability to reduce HIV infection and transmission depends on testing, in particular assessing the status of at-risk people who continue to remain untested.
In this issue, Dr. Cedric Bien-Gund from the Division of Infectious Diseases at the University of Pennsylvania takes us to the clinic to explain the pros and cons of the currently available HIV tests and explains which are best to use in particular clinical circumstances.
Fellow in Infectious Diseases
Division of Infectious Diseases
Department of Medicine
University of Pennsylvania Perelman School of Medicine
Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)
Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)
Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)
0.5 hour Physicians
0.5 contact hour Nurses
Launch date: July 9, 2020
Expiration date: July 8, 2022